Rosie Ackerman-Johnson

Rosie Ackerman-Johnson is currently the Head of Regulatory Affairs & Quality at Theolytics, focusing on advancing a novel oncolytic virus into clinical trials since January 2023. Previously, Rosie served as Senior Regulatory Affairs Manager and Senior Manager of Regulatory Affairs at Diamond Pharma Services, where responsibilities included managing clinical trial submissions for ATMPs across Europe, consulting on scientific advice submissions, and overseeing regulatory affairs projects. Rosie also led a team in an outsourced clinical trials regulatory department, ensuring efficient submission processes to UK and Irish authorities. Other positions include roles at Teva Pharmaceuticals and Consilient Health, where responsibilities encompassed regulatory affairs, pharmacovigilance, and quality assurance. Rosie holds a Bachelor's Degree in Biomedical Sciences from The University of Sheffield.